An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease

被引：0
|
作者：
Shua-Haim, JR [1 ]
Pass, MD [1 ]
Patel, S [1 ]
Lee, P [1 ]
Patel, P [1 ]
机构：
[1] Jersey Shore Univ Med Ctr, Neptune, NJ USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80659-6
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S196 / S196
页数：1
相关论文
共 50 条
  • [1] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment for treatment of Alzheimer's disease
    Shua-Haim, JR
    Pass, M
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 356 - 356
  • [2] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease.
    Shua-Haim, JR
    Pass, MD
    Smith, J
    Lee, PP
    Patel, S
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S93 - S93
  • [3] Safety, tolerability and clinical impression of high dose rivastigmine treatment for patients with Alzheimer's disease (AD)
    Shua-Haim, J
    Patel, S
    Smith, J
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 232 - 233
  • [4] Investigation of safety, tolerability, and efficacy of high dose (15-17.5 mg/day) rivastigmine (exelon) treatment for Alzheimer's disease patients.
    Pass, M
    Shua-Haim, J
    Patel, S
    [J]. GERONTOLOGIST, 2003, 43 : 165 - 165
  • [5] Rivastigmine and Concomitant Memantine in Alzheimer's Disease: Safety and Tolerability
    Safirstein, Beth
    Meng, Xiangyi
    Olin, Jason T.
    [J]. CNS SPECTRUMS, 2010, 15 (09) : 594 - 598
  • [6] Safety, tolerability, and caregiver's impressions of combination therapy with rivastigmine and memantine for the treatment of Alzheimer's disease
    Shua-Haim, JR
    Pass, MD
    Patel, S
    Patel, S
    Lee, P
    Smith, J
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S205 - S205
  • [7] Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia
    Darreh-Shori, Taher
    Jelic, Vesna
    [J]. EXPERT OPINION ON DRUG SAFETY, 2010, 9 (01) : 167 - 176
  • [8] Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer's disease in daily practice
    Seibert, Johannes
    Tracik, Ferenc
    Articus, Konstantin
    Spittler, Stefan
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 141 - 147
  • [9] Safety and tolerability of rivastigmine capsules plus memantine in patients with probable Alzheimer's disease
    Brannan, Stephen
    Koumaras, Barbara
    Figiel, Gary
    Farlow, Martin
    [J]. ANNALS OF NEUROLOGY, 2008, 64 : S40 - S41
  • [10] Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese Patients with Alzheimer's Disease A Prospective Post-Marketing Surveillance Study
    Chiu, Pai-Yi
    Dai, Dao-En
    Hsu, Hai-Pei
    Lee, Chao
    Lin, Juei-Jueng
    Kuo, Hung-Chou
    Huang, Ying-Chih
    Liu, Yung-Chang
    Tsai, Ching-Piao
    [J]. CLINICAL DRUG INVESTIGATION, 2009, 29 (11) : 729 - 738
12345